Royalty Pharma News

Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Hite Christopher

May 16 16:47

Royalty Pharma | 10-Q: Quarterly report

May 9 08:10

Royalty Pharma | 8-K: ROYALTY PHARMA REPORTS FIRST QUARTER 2024 RESULTS

May 9 06:22

Royalty Pharma | DEF 14A: Definitive information statements

Apr 25 21:17

Royalty Pharma | ARS: Annual Report to Security Holders

Apr 25 15:14

Royalty Pharma | DEFA14A: Others

Apr 25 15:12

Royalty Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 3 15:53

Royalty Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 3 15:53

Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Director Fernandez Henry A

Apr 2 16:36

Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Director Bassler Bonnie L

Apr 2 16:32

Royalty Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 28 21:46

Royalty Pharma | 4: Statement of changes in beneficial ownership of securities-Director RIGGS RORY B

Feb 22 18:28

Royalty Pharma | 10-K: Annual report

Feb 15 08:12

Royalty Pharma | 8-K: Current report

Feb 15 06:37

Royalty Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(8.54%)

Feb 13 21:37

Royalty Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-General Atlantic, L.P.(5.6%),GAP Coinvestments CDA, L.P.(5.6%), etc.

Feb 13 09:20

Royalty Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Morgan Stanley(9.2%),Morgan Stanley Investment Management Inc.(8.9%)

Feb 9 14:15

Royalty Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(7.099%),Abigail P. Johnson(7.099%)

Feb 9 08:55

Royalty Pharma | 8-K: Current report

Feb 6 06:06

Royalty Pharma | UPLOAD: Others

Jan 30 13:35